ADM
47
2
APH
56
7
HRL
23
-12
BRK.B
33
-14
PBI
68
2
NDAQ
74
4
APD
45
-2
DTE
38
-4
RIG
40
2
CCI
36
2
CHRW
82
3
FE
48
-4
CMI
71
2
PYPL
52
2
AME
72
6
DRI
66
2
APA
53
5
T
23
2
VTR
67
-3
CI
48
-4
ADM
47
2
APH
56
7
HRL
23
-12
BRK.B
33
-14
PBI
68
2
NDAQ
74
4
APD
45
-2
DTE
38
-4
RIG
40
2
CCI
36
2
CHRW
82
3
FE
48
-4
CMI
71
2
PYPL
52
2
AME
72
6
DRI
66
2
APA
53
5
T
23
2
VTR
67
-3
CI
48
-4
Financhill
Back

The New York Times Co. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Buy
86

NYT
The New York Times Co.

Last Price:
$70.79
Seasonality Move:
5.79%
Sell
23

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$33.50
Seasonality Move:
-0.96%
Buy
86
The New York Times Co. (NYT) is a Buy

Is The New York Times Co. a Buy, Sell or Hold?

  • The current The New York Times Co. [NYT] share price is $70.79. The Score for NYT is 86, which is 72% above its historic median score of 50, and infers lower risk than normal.
  • NYT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
23
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.50. The Score for RARE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NYT Stock Price Chart

What is The New York Times Co.'s stock price today?

  • The The New York Times Co. share price today is $70.79
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NYT is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $33.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight buying pressure.

NYT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.19 Buy
Relative Strength Index (14 RSI): 81.3 Buy
Chaikin Money Flow: -68133 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.45 - 67.91) Buy
Bollinger Bands (100): (55.74 - 63.94) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.24 Buy
Relative Strength Index (14 RSI): 45.54 Sell
Chaikin Money Flow: 579058 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.65 - 35.95) Sell
Bollinger Bands (100): (29.19 - 34.19) Buy

NYT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 68.65 Buy
20-day SMA: 66.2 Buy
50-day SMA: 61.77 Buy
200-day SMA: 56.22 Buy
8-day EMA: 68.7 Buy
20-day EMA: 66.52 Buy
50-day EMA: 63.24 Buy
200-day EMA: 57.7 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.82 Sell
20-day SMA: 34.8 Sell
50-day SMA: 33.74 Sell
200-day SMA: 33.57 Sell
8-day EMA: 17.59 Buy
20-day EMA: 8.61 Buy
50-day EMA: 3.75 Buy
200-day EMA: 0.98 Buy

The New York Times Co. Earnings Growth & NYT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.25 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

The New York Times Co. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):